novel strategies to optimize car-t therapy in myeloma
Published 3 years ago • 113 plays • Length 2:49Download video MP4
Download video MP3
Similar videos
-
2:57
strategies to optimize car-t therapy in myeloma: bringing car-t into earlier lines
-
4:23
novel strategies to optimize car t-cell therapy
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
2:05
novel car-t constructs being explored in myeloma: t-charge platform
-
5:10
what is multiple myeloma? - animated
-
5:52
chimeric antigen receptor (car) / car-t
-
9:25
mgus diagnosis: a step-by-step approach
-
0:47
novel targets in car-t therapy for multiple myeloma: integrin beta-7 & cd98 heavy chain
-
1:12
novel all treatment strategies: car t-cells
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
2:27
bms-986393, a novel anti-gprc5d car-t cell therapy, in multiple myeloma
-
14:10
highlights in multiple myeloma: improving access to car-t therapy, novel targets & future outlooks
-
1:34
cctx-001: a novel car-t therapy for aml
-
0:58
novel car-t constructs emerging in multiple myeloma for patients who experience loss of bcma
-
0:52
novel strategies to evaluate biomarkers of interest in multiple myeloma
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
2:16
the sequencing of novel therapies in myeloma (car-t, bispecifics, antibody-drug conjugates)
-
2:20
novel car-t products in the pipeline for multiple myeloma
-
3:07
the role of bridging and timing in car-t
-
1:06
moving car-t therapy to earlier lines in multiple myeloma and clinical trials in this space
-
4:58
novel immunotherapies transforming r/r myeloma treatment: bispecifics, car-t cells & more